Thermo Fisher Scientific Prices $3.8 Billion Senior Notes Offering
TMO sits 42% above its 52-week low of $385.46.
Summary
Thermo Fisher Scientific Inc. has finalized the pricing for a multi-tranche senior notes offering totaling $3.8 billion, with maturities ranging from 2031 to 2046.
Key Events · Financing and Capital Events · TMO
-
Pricing Finalized for Senior Notes
The company priced four tranches of senior notes: $1.0 billion due 2031 at 4.215%, $750 million due 2033 at 4.550%, $1.3 billion due 2036 at 4.902%, and $750 million due 2046 at 5.546%.
-
Substantial Capital Raise
The aggregate principal amount of the offering totals $3.8 billion, representing a significant financing event for the company.
-
Market-Aligned Terms
The notes were issued at or near par, with yields reflecting current market conditions, indicating a standard debt financing transaction.
Analysis · TMO · Industrial Applications And Services
This Free Writing Prospectus finalizes the terms and pricing of a multi-tranche senior notes offering, likely initiated with the 424B5 filing on the same day. Thermo Fisher Scientific is raising a substantial $3.8 billion through four tranches of senior notes with maturities ranging from 2031 to 2046 and coupon rates between 4.215% and 5.546%. This debt issuance represents a significant financing activity for the company, providing capital for general corporate purposes and reflecting standard treasury management for a large enterprise. The pricing appears to be in line with market conditions, indicating a routine capital raise rather than a distressed financing event.
At the time of this filing, TMO was trading at $546.76 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $205.4B. The 52-week trading range was $385.46 to $643.99. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.